Information  X 
Enter a valid email address

Pets at Home Grp (PETS)

  Print      Mail a friend

Friday 14 September, 2018

Pets at Home Grp

Director/PDMR Shareholding

RNS Number : 8738A
Pets At Home Group Plc
14 September 2018
 

14 September 2018

Pets at Home Group plc

Director/PDMR Shareholding

 

  

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Peter Pritchard

2.

Reason for the notification

(a)

Position/status

Group Chief Executive Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Pets at Home Group Plc

(b)

LEI

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.01 nominal value each in the capital of Pets at Home Group Plc

(b)

Identification code of the Financial Instrument

GB00BJ62K685

(c)

Nature of the transaction

Peter Pritchard  has cancelled his participation in the 2017 offer under the Pets at Home Group Sharesave scheme and discontinued his monthly contributions resulting in a lapsing of the Options originally granted to him on 11 October 2017 with an exercise price £1.572 per share. The Sharesave is a tax advantaged share scheme offered to all eligible employees of the Company.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)



£1.572 per share

11,450

(e)

Aggregated information

-               Aggregated volume

-               Price

N/A

(f)

Date of the transaction

14 September  2018

(g)

Place of the transaction

London Stock Exchange (XLON)

 

Enquiries:

 

Louise Stonier

Chief People and Legal Officer/ Company Secretary

Pets At Home Group plc

Tel: 0161 486 3590


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHFKQDKPBKDKCD

a d v e r t i s e m e n t